Potential protective role of Grainyhead-like genes in the development of clear cell renal cell carcinoma.
Magdalena PawlakAgnieszka KikulskaTomasz WrzesinskiTobias RauschZbigniew KwiasBartek WilczynskiVladimir BenesJoanna WesolyTomasz WilanowskiPublished in: Molecular carcinogenesis (2017)
The involvement of Grainyhead-like (GRHL) transcription factors in various cancers is well documented. However, little is known about their role in clear cell renal cell carcinoma (ccRCC). We discovered that the expression of two of these factors-GRHL1 and GRHL2-are downregulated in ccRCC samples, and their expression is correlated with the expression of VHL gene. This suggests a functional link between the GRHL transcription factors and one of the best known tumor suppressors. Although the GRHL genes are not mutated in ccRCC, some of the single nucleotide polymorphisms in these genes may indicate an increased risk of ccRCC development and/or may allow to assess patients' prognoses and predict their responses to various forms of therapy. Silencing of GRHL2 expression in non-tumorigenic kidney cell line results in increased cell proliferation, increased resistance to apoptosis, as well as changes in the levels of selected proteins involved in the pathogenesis of ccRCC. These changes support the potential role for GRHL2 as a suppressor of ccRCC.
Keyphrases
- poor prognosis
- genome wide identification
- transcription factor
- genome wide
- cell proliferation
- end stage renal disease
- chronic kidney disease
- oxidative stress
- newly diagnosed
- long non coding rna
- ejection fraction
- risk assessment
- stem cells
- bioinformatics analysis
- dna methylation
- cell cycle
- peritoneal dialysis
- dna binding
- cell cycle arrest
- patient reported outcomes
- patient reported